Flash Pulmonary Edema

Progress in Cardiovascular Diseases

Volumn 52, Issue 3, 2009, Pages 249-259

  Rimoldi, Stefano F ^a   Yuzefpolskaya, Melana ^b   Allemann, Yves ^a   Messerli, Franz ^b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; FUROSEMIDE; GLYCERYL TRINITRATE; LOOP DIURETIC AGENT; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ACUTE DECOMPENSATED HEART FAILURE; ARTICLE; AUTOREGULATION; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; FLASH PULMONARY EDEMA; HEART FAILURE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; LUNG EDEMA; LUNG FLUID; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; TAKOTSUBO CARDIOMYOPATHY; VALVULAR HEART DISEASE;

DIAGNOSIS, DIFFERENTIAL; HEART FAILURE; HUMANS; PULMONARY EDEMA; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 71549117267     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.10.002     Document Type: Article

References (112)

1. Ware L.B., and Matthay M.A. Clinical practice. Acute pulmonary edema. N Engl J Med 353 (2005) 2788-2796
2. Pickering T.G., Herman L., Devereux R.B., et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 2 (1988) 551-552
3. Diamond J.R. Flash pulmonary edema and the diagnostic suspicion of occult renal artery stenosis. Am J Kidney Dis 21 (1993) 328-330
4. Connolly J.O., Higgins R.M., Walters H.L., et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 87 (1994) 413-421
5. Bloch M.J., Trost D.W., Pickering T.G., et al. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens 12 1 Pt 1 (1999) 1-7
6. Mancia G., Grassi G., Saino A., et al. Reflex control of renin release in normotensive and hypertensive humans. In: Glorioso N., Laragh J.H., and Rappelli A. (Eds). Renovascular hypertension (1987), Raven Press, New York 159-173
7. Kunis R., Greenberg H., Yeoh C.B., et al. Coronary revascularization for recurrent pulmonary edema in elderly patients with ischemic heart disease and preserved ventricular function. N Engl J Med 313 (1985) 1207-1210
8. Sartori C., Allemann Y., and Scherrer U. Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema. Respir Physiol Neurobiol 159 (2007) 338-349
9. Heard B.E., Steiner R.E., Herdan A., et al. Oedema and fibrosis of the lungs in left ventricular failure. Br J Radiol 41 (1968) 161-171
10. Jordan S.C., Hicken P., Watson D.A., et al. Pathology of the lungs in mitral stenosis in relation to respiratory function and pulmonary haemodynamics. Br Heart J 28 (1966) 101-107
11. Tandon H.D., and Kasturi J. Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J 37 (1975) 26-36
12. Gehlbach B.K., and Geppert E. The pulmonary manifestations of left heart failure. Chest 125 (2004) 669-682
13. Matthay M.A., Folkesson H.G., and Verkman A.S. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 270 4 Pt 1 (1996) L487-L503
14. Matalon S., and O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 61 (1999) 627-661
15. Sartori C., Matthay M.A., and Scherrer U. Transepithelial sodium and water transport in the lung. Major player and novel therapeutic target in pulmonary edema. Adv Exp Med Biol 502 (2001) 315-338
16. Looney M.R., Sartori C., Chakraborty S., et al. Decreased expression of both the alpha1- and alpha2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance. Am J Physiol Lung Cell Mol Physiol 289 (2005) L104-L110
17. West J.B., Tsukimoto K., Mathieu-Costello O., et al. Stress failure in pulmonary capillaries. J Appl Physiol 70 (1991) 1731-1742
18. West J.B., and Mathieu-Costello O. Stress-induced injury of pulmonary capillaries. Proc Assoc Am Physicians 110 (1998) 506-512
19. West J.B. Invited review: pulmonary capillary stress failure. J Appl Physiol 89 (2000) 2483-2489 [discussion 2497]
20. West J.B., and Mathieu-Costello O. Stress failure of pulmonary capillaries in the intensive care setting. Schweiz Med Wochenschr 122 (1992) 751-757
21. Halpern P., Gefen A., Sorkine P., et al. Pulmonary oedema in SCUBA divers: pathophysiology and computed risk analysis. Eur J Emerg Med 10 (2003) 35-41
22. Hopkins S.R., Gavin T.P., Siafakas N.M., et al. Effect of prolonged, heavy exercise on pulmonary gas exchange in athletes. J Appl Physiol 85 (1998) 1523-1532
23. Hopkins S.R., Schoene R.B., Henderson W.R., et al. Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med 155 (1997) 1090-1094
24. Elliott A.R., Fu Z., Tsukimoto K., et al. Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol 73 (1992) 1150-1158
25. Lohmeier T.E., Mizelle H.L., Reinhart G.A., et al. Influence of angiotensin on the early progression of heart failure. Am J Physiol. Regulatory Integrative Comp. Physiol 278 (2000) R74-R86
26. Hall J.E., Granger J.P., Hester R.L., et al. Mechanisms of escape from sodium retention during angiotensin II hypertension. Am J Physiol 246 5 Pt 2 (1984) F627-F634
27. Marshall R.P. The pulmonary renin-angiotensin system. Curr Pharm Des 9 (2003) 715-722
28. Guazzi M., Brambilla R., Agostoni P., et al. Influence of ACE-inhibition on salt-mediated worsening of pulmonary gas exchange in heart failure. Br J Clin Pharmacol 51 (2001) 482-487
29. Guazzi M., Melzi G., Marenzi G.C., et al. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction. Clin Pharmacol Ther 65 (1999) 319-327
30. Paulus W.J., Vantrimpont P.J., and Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89 (1994) 2070-2078
31. Prendergast B.D., Sagach V.F., and Shah A.M. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96 (1997) 1320-1329
32. Vrints C.J., Bult H., Bosmans J., et al. Paradoxical vasoconstriction as result of acetylcholine and serotonin in diseased human coronary arteries. Eur Heart J 13 (1992) 824-831
33. Sartori C., Lepori M., and Scherrer U. Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharmacol Ther 106 (2005) 209-220
34. Yin N., Kaestle S., Yin J., et al. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease. Crit Care Med 37 (2009) 980-986
35. Bech J.N., Nielsen C.B., Ivarsen P., et al. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol 274 5 Pt 2 (1998) F914-F923
36. McEniery C.M., Qasem A., Schmitt M., et al. Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 42 (2003) 1975-1981
37. MacCarthy P.A., Grocott-Mason R., Prendergast B.D., et al. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation 101 (2000) 142-147
38. de Nucci G., Thomas R., D'Orleans-Juste P., et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85 (1988) 9797-9800
39. Cowburn P.J., Cleland J.G., McArthur J.D., et al. Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 33 (1999) 932-938
40. Milo O., Cotter G., Kaluski E., et al. Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 92 (2003) 222-226
41. Sartori C., Vollenweider L., Loffler B.M., et al. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 99 (1999) 2665-2668
42. Carpenter T.C., Schomberg S., and Stenmark K.R. Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia. Am J Physiol Lung Cell Mol Physiol 289 (2005) L1075-L1082
43. Carpenter T., Schomberg S., Steudel W., et al. Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression. Circ Res 93 (2003) 456-463
44. Berger M.M., Rozendal C.S., Schieber C., et al. The effect of endothelin-1 on alveolar fluid clearance and pulmonary edema formation in the rat. Anesth Analg 108 (2009) 225-231
45. King A.J., Brenner B.M., and Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 256 6 Pt 2 (1989) F1051-F1058
46. Ding S.S., Qiu C., Hess P., et al. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure. Cardiovasc Res 53 (2002) 963-970
47. Wong N.L., Sonntag M., and Tsui J.K. Attenuation of renal vasopressin V2 receptor upregulation by bosentan, an ETA/ETB receptor antagonist. Metabolism 52 (2003) 1141-1146
48. Lenders J.W., Eisenhofer G., Mannelli M., et al. Phaeochromocytoma. Lancet 366 (2005) 665-675
49. Yamanaka O., Yasumasa F., Nakamura T., et al. "Myocardial stunning"-like phenomenon during a crisis of pheochromocytoma. Jpn Circ J 58 (1994) 737-742
50. Krasney J.A. A neurogenic basis for acute altitude illness. Med Sci Sports Exerc 26 (1994) 195-208
51. Nef H.M., Mollmann H., and Elsasser A. Tako-tsubo cardiomyopathy (apical ballooning). Heart 93 (2007) 1309-1315
52. Mottram P.M., Haluska B.A., Leano R., et al. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 91 (2005) 1551-1556
53. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
54. Mosterd A., Hoes A.W., de Bruyne M.C., et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20 (1999) 447-455
55. Vasan R.S., Benjamin E.J., and Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26 (1995) 1565-1574
56. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
57. Gandhi S.K., Powers J.C., Nomeir A.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344 (2001) 17-22
58. Verdecchia P., Schillaci G., Guerrieri M., et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81 (1990) 528-536
59. Haider A.W., Larson M.G., Franklin S.S., et al. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 138 (2003) 10-16
60. Ingelsson E., Bjorklund-Bodegard K., Lind L., et al. Diurnal blood pressure pattern and risk of congestive heart failure. Jama 295 (2006) 2859-2866
61. Goyal D., Macfadyen R.J., Watson R.D., et al. Ambulatory blood pressure monitoring in heart failure: a systematic review. Eur J Heart Fail 7 (2005) 149-156
62. Higashi Y., Nakagawa K., Kimura M., et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol 40 (2002) 2039-2043
63. Carvalho M.J., van Den Meiracker A.H., Boomsma F., et al. Diurnal blood pressure variation in progressive autonomic failure. Hypertension 35 (2000) 892-897
64. Sherwood A., Steffen P.R., Blumenthal J.A., et al. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens 15 2 Pt 1 (2002) 111-118
65. Lee K.W., Blann A.D., and Lip G.Y. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 18 (2005) 104-115
66. von Kanel R., Jain S., Mills P.J., et al. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens 22 (2004) 2087-2093
67. Hirschl M.M., Schreiber W., Bur A., et al. Hormonal derangements in patients with acute congestive heart failure. Am J Hypertens 9 (1996) 49A
68. Richards A.M., Nicholls M.G., Troughton R.W., et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 39 (2002) 1182-1188
69. Garovic V.D., and Textor S.C. Renovascular hypertension and ischemic nephropathy. Circulation 112 (2005) 1362-1374
70. Zeller T., Rastan A., Schwarzwalder U., et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther 14 (2007) 189-197
71. Yusuf S., Zhao F., Mehta S.R., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
72. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
73. Yusuf S., Pepine C.J., Garces C., et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340 (1992) 1173-1178
74. Beohar N., Erdogan A.K., Lee D.C., et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol 52 (2008) 13-16
75. Kramer K., Kirkman P., Kitzman D., et al. Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 140 (2000) 451-455
76. Pierard L.A., and Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351 (2004) 1627-1634
77. Lancellotti P., Troisfontaines P., Toussaint A.C., et al. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108 (2003) 1713-1717
78. Lebrun F., Lancellotti P., and Pierard L.A. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 38 (2001) 1685-1692
79. Lancellotti P., Gerard P.L., and Pierard L.A. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 26 (2005) 1528-1532
80. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. Jama 283 (2000) 1829-1836
81. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157 (1997) 1746-1752
82. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
83. Kuniyoshi F.H., and Somers V.K. Sleep apnea in hypertension: when, how, and why should we treat?. Hypertension 47 (2006) 818-819
84. Chaudhary B.A., Ferguson D.S., and Speir Jr. W.A. Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest 82 (1982) 122-124
85. Chaudhary B.A., Nadimi M., Chaudhary T.K., et al. Pulmonary edema due to obstructive sleep apnea. South Med J 77 (1984) 499-501
86. Chaudhary B.A., Chaudhary T.K., and Speier W.A. Progressive dyspnea and pulmonary edema in an obese somnolent man. J Med Assoc Ga 76 (1987) 133-135
87. Fletcher E.C., Proctor M., Yu J., et al. Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med 160 5 Pt 1 (1999) 1688-1696
88. Kato M., Roberts-Thomson P., Phillips B.G., et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102 (2000) 2607-2610
89. Shamsuzzaman A.S., Gersh B.J., and Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. Jama 290 (2003) 1906-1914
90. Lattimore J.D., Celermajer D.S., and Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41 (2003) 1429-1437
91. Floras J.S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54 (2009) 375-385
92. Tolle F.A., Judy W.V., Yu P.L., et al. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 55 (1983) 1718-1724
93. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
94. Dote K., Sato H., Tateishi H., et al. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21 (1991) 203-214
95. Wittstein I.S., Thiemann D.R., Lima J.A., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352 (2005) 539-548
96. Bybee K.A., Kara T., Prasad A., et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 141 (2004) 858-865
97. Gianni M., Dentali F., Grandi A.M., et al. Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J 27 (2006) 1523-1529
98. Desmet W.J., Adriaenssens B.F., and Dens J.A. Apical ballooning of the left ventricle: first series in white patients. Heart 89 (2003) 1027-1031
99. Bybee K.A., Prasad A., Barsness G.W., et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol 94 (2004) 343-346
100. Gheorghiade M., and Pang P.S. Acute heart failure syndromes. J Am Coll Cardiol 53 (2009) 557-573
101. Greenberg S., McGowan C., Xie J., et al. Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine. J Pharmacol Exp Ther 270 (1994) 1077-1085
102. Stanke F., Devillier P., Breant D., et al. Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle. Br J Clin Pharmacol 46 (1998) 571-575
103. Scherrer U., Vollenweider L., Delabays A., et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 334 (1996) 624-629
104. Torre-Amione G., Young J.B., Colucci W.S., et al. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 42 (2003) 140-147
105. Zhao L., Mason N.A., Morrell N.W., et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104 (2001) 424-428
106. Hackett P.H., Roach R.C., Hartig G.S., et al. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Int J Sports Med 13 Suppl 1 (1992) S68-S71
107. O'Connor C.M., Velazquez E.J., Gardner L.H., et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 90 (2002) 101-107
108. Alderman E.L., Fisher L.D., Litwin P., et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68 (1983) 785-795
109. Baker D.W., Jones R., Hodges J., et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. Jama 272 (1994) 1528-1534
110. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104 (2001) 191-196
111. Higashi Y., Oshima T., Ozono R., et al. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension 25 4 Pt 2 (1995) 898-902
112. Higashi Y., Sasaki S., Kurisu S., et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 100 (1999) 1194-1202